Angiomyolipoma — Trials

Angiomyolipoma — Trials · CancerIndex

Clinical trials

Registered studies

10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–10 of 10 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05252585	A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)	active not recruiting	Phase 4	4	Novartis PharmaceuticalsINDUSTRY	1	Sep 17, 2026	clinicaltrials
NCT06453642	Evaluation of a Simple-Prep Controlled Embolic(GPX)	active not recruiting	N/A	114	Fluidx Medical Technology, Inc.INDUSTRY	3	Mar 30, 2026	clinicaltrials
NCT06683846	Ivonescimab in the Treatment of Multiple Advanced Tumors	recruiting	Phase 2	400	Fudan UniversityOTHER	1	Aug 24, 2025	clinicaltrials
NCT05785052	Biomarkers of Renal Cancer

Data updated 13 days agoSource updated Sep 17, 2026source: clinicaltrials